Thursday, May 1, 2008
7:00 am Breakfast |
|
8:00 Welcome Remarks – State of the Market and State of Symyx
Timothy Campbell, President, Symyx Software
8:15 Symyx Software Roadmap
Trevor W. Heritage, Ph.D., Senior Vice President, Science, Symyx Software
Trevor’s presentation will discuss the exciting potential customers are already seeing in Symyx Software’s product road map-their ability to start in Symyx Notebook and never leave and their ability to start in Symyx Isentris and go anywhere. Trevor will outline development plans for 2008 and 2009, specifically addressing Symyx Notebook and Symyx
Isentris, as well as Symyx Draw, ISIS, DiscoveryGate, Automation Studio and Analysis Studio. He will also highlight specific areas within discovery and development including: biology, catalysis, medicinal chemistry, process, formulations and analytical.
|
|
9:15 Networking Coffee Break
|
Development Track
DRIVING EFFICIENCY IN
PROCESS R&D WITH SYMYX SOFTWARE
9:40 Chairperson’s Remarks
Randy Clark, Vice President, Marketing, Symyx Technologies, Inc.
9:50 Upgrading a Global Deployment of Symyx Process Notebook and Subsequent Exploitation of the New Capabilities
Ian Menzies, Senior Informations Manager,Business Development, AstraZeneca,
Global Process R&D
This talk will look at the upgrade process used by AstraZeneca to move from IntelliChem version 4.2 to version 5.4 of Symyx Process Notebook. It will also discuss how we have made use of the workflow features of Vault 5.08 to help us utilize the software for early phase GMP manufacture.
10:20 Bringing Green Chemistry to the Scientist via ELN at Eli Lilly and Company
Michael E. Kopach, Ph.D., Principal Research Scientist, Chemical Product R&D, Eli Lilly & Co.
Since the initial deployment of a fully electronic lab notebook at Eli Lilly and Company in 2004, numerous organizational efficiencies have been achieved. For commercial R&D processes, minimization of waste and elimination of hazardous solvents are important environmental objectives. To assist with these green chemistry goals, an ELN customization has been developed and successfully beta tested which determines the Process Mass intensity (PMI) for a specific step and an entire process. In addition, the new tool reports Toxic Release Inventory (TRI) chemicals and classifies all solvents with an environmental rating.
10:50 Thin Client Computing with the Symyx ELN
Jeff Dziedzic, Applications Specialist, Bristol-Myers Squibb Co.
The purpose of this presentation is to examine some of the challenges that may occur when implementing the Symyx Notebook (ELN) and to demonstrate a viable solution to these issues. When operating in a fully electronic world, hardware components must be in place to help maximize the efficiency of the laboratory scientist. Some of the challenges faced result from scientists writing notes on paper, contamination from laptops moving in and out of the lab environment, and document tracking. Thin client computing offers a solution to accessing the Symyx Notebook while working effectively in a remote lab.
11:20 Move
to Breakout Discussions
|
|
11:30 pm Birds of a Feather
Discussions
|
|
12:30 Networking
Lunch
|
|
1:25 Move to Combined Session
|
|
1:30 Symyx Notebook 6 Update
John McCarthy, Vice President, Applications Product Management, Symyx
Technologies, Inc.
Symyx Notebook 6 is the next generation in long history of delivering electronic
laboratory notebooks to our customers. Symyx Notebook 6 is both a platform and
an application. The platform provides document management and versioning,
document workflows and document indexing. The application is tailored to the
specific needs of the scientist be it analytical, medicinal chemistry or
biology. In this presentation, we will discuss how Symyx Notebook 6 is
delivering both platform and a universal application that meets all your ELN
needs.
|
|
2:00 Symyx Isentris - Supporting Personal and Corporate Data Access and Decision Support
Dominic John, Isentris Group Manager, Symyx Technologies, Inc
Isentris 3.0 released in October 2007 provided many new capabilities to support scientists accessing corporate and commercial data, making decisions and sharing information. In 2008 Symyx will release Isentris Personal to support offline data access, personal data repositories and information exchange with collaborators such as CRO’s, off-shore facilities and academic partners. This session will cover the key new capabilities, including application demonstrations and the opportunities these new features provide research organizations and scientists.
|
|
2:30 Isentris Demonstration
|
Development Track
ADDING VALUE THROUGH SYMYX
SOFTWARE IN DEVELOPMENT
2:45 Chairperson’s Remarks
Randy Clark, Vice President, Marketing, Symyx Technologies, Inc.
2:55 High-Throughput Reaction Screening: When More is Less
Robert Wade, D. Phil., Research Fellow, Pfizer Inc.
We have had high-throughput screening groups at multiple Pfizer sites for many years now. However, much of the workflow is quite heterogeneous with respect to hardware and software and the resulting volumes of raw and processed data are not readily accessible for general perusal or data-mining. This talk will illustrate our efforts to utilize the Symyx Software informatics platform and integration with third-party hardware/software and provide significantly faster turnaround for screening requests.
3:25 Managing
Physical Property Data on Crystalline Phases in a Global Organization
Timothy A. Rhodes, Ph.D., Research Fellow, Center for Physicochemical Characterization, Merck Research Laboratories
Automation
results in large volumes of data and creates new information technology
challenges. For example, automated data loading is essential to manage the
volume of spectroscopic data generated in high throughput salt and polymorph
screening. However, data that are added automatically do not get reviewed during
the loading process, necessitating a process to flag poor quality data.
Furthermore, not all relevant information is collected via automation, and
additional information needs to be manually entered. In order to find and
analyze information rapidly, search tools such as spectral matching are needed
to query the database. Browse and viewing capabilities are also required for
analysis. Finally, it is necessary to track conclusions based on the information
collected. Analysts from across the street and across the globe needed a simple
unified way to view, compare and search crystalline phase information at every
stage of development. A system was created to track, organize, and curate data
related to crystalline phase discovery. The system can handle all information on
phases, as it tracks spectra, tables, text, and images. Multiple sources are
possible, as data are loaded during automation, manually from files, and
manually via a Microsoft Excel-based entry tool. A spectral searching tool aids
identification of novel crystalline phases. Additionally, a review process
organizes all information on possible new phases to help ensure correct
identification and maintain high quality analytical data. Users interact with a
web application to load, browse, search, view, overlay, and review data, so it
is readily available and simpler to manage.
|
3:55 Networking Refreshment Break
|
4:15 Notebook Integration – What’s In It For Me?
Stephen Taylor, Ph.D., Director, Project & Process Optimization Systems, Process R&D, Bristol-Myers Squibb Pharmaceutical Research Institute
An overview of the opportunities for ELN integration leveraging notebook content to support connectivity to existing systems and data transfer back to the ELN. Such integration can improve the users’ productivity, eliminate duplication of effort, eliminate errors, and provide context to data in disparate systems. Integration should go beyond supporting existing workflows and enable scientists to gain insights into their data. The factors that should be considered when integrating will be reviewed, including when to integrate and when not to integrate
4:45 Use of Symyx Notebook with External Partners
Jeffrey Christofferson, Symyx Notebook Program Team Leader, Product Research & Development, Eli Lilly and Company,
Inc.
As organizations look to accomplish work in different ways, the issue of extending the supporting IT infrastructure to third party partner presents unique challenges. Technical as well as process limitations must be addressed to be able to move effectively to meet the demands of the mode of operation. As Eli Lilly and Company have taken our initial steps, perspectives will be offered on the obstacles that have been overcome and what future ones still remain.
|
5:15 Move to Combined Session
|
|
5:20 Panel Discussion:
INTEGRATED
R&D – HOW FAR HAVE WE COME? WHAT HAVE WE LEARNED HERE?
Panelists: Chris Waller, Ph.D., Senior Director, Pfizer Global Research and Development
Ian Menzies, GP R&D Business Development, AstraZeneca Pharmaceuticals
Michael E. Kopach, Ph.D., Principal Research Scientist, Chemical Product R&D, Eli Lilly & Co.
David M. Sedlock, Ph.D., Director, Research Systems, Millennium Pharmaceuticals Inc.
5:50 Closing Remarks & Wrap-up
Timothy Campbell, President, Symyx Software
|
|
6:00 Networking Reception
|
Friday, May 2, 2008
8:30am - 12:00pm Software Advisory Board (by invitation only)
|
|